Enhanced hepatocyte colony growth in soft agar after in vivo treatment with a genotoxic carcinogen: a potential assay for hepatocarcinogens?
We have shown previously that approximately 1 in 10,000 primary hepatocytes isolated from untreated rats undergo clonal growth in soft agar in vitro in response to the synergistic action of nafenopin, a peroxisome proliferator (PP) and epidermal growth factor (EGF), a naturally occurring liver growth regulator. Here, we demonstrate that prior treatment of the animals with the genotoxic hepatocarcinogen diethylnitrosamine (DEN) caused a dose-dependent increase in soft agar colony numbers formed in vitro. These data suggest that the colony assay may offer a method of detecting in vitro hepatocytes transformed in vivo by DEN. It is known that rats treated with DEN develop enzyme altered foci prior to the development of tumours. The majority of these foci express high levels of gamma-glutamyl transpeptidase (GGT). However, foci promoted by PPs do not show this increased enzyme activity. In the present study, the colonies we have generated in vitro mimicked this pattern since the majority (approximately 80%) of the spontaneous colonies expressed GGT whereas colonies promoted by the synergistic action of nafenopin and EGF were mainly (75%) GGT negative. The proportion of colonies positive for GGT were similar using either hepatocytes isolated from control or from DEN-initiated rats. Further studies are required to assess if the hepatocytes selected for clonal expansion by this EGF/nafenopin regime reflect the presumed pre-neoplastic cells induced by genotoxin in vivo and associated with an increased propensity to cancer.
James
N H
NH
Zeneca Central Toxicology Laboratory, Macclesfield, UK.
Ashby
J
J
Roberts
R A
RA
D000362:Agar; D000818:Animals; D015197:Carcinogenicity Tests / Q000379:methods*; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D002478:Cells, Cultured; D003260:Contact Inhibition / Q000187:drug effects*; D004052:Diethylnitrosamine; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D004815:Epidermal Growth Factor / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D008113:Liver Neoplasms / Q000139:chemically induced*; D008297:Male; D009255:Nafenopin / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D014410:Tumor Stem Cell Assay / Q000379:methods*; D005723:gamma-Glutamyltransferase
D009255:Nafenopin; D004052:Diethylnitrosamine; D004815:Epidermal Growth Factor; D000362:Agar; D005723:gamma-Glutamyltransferase